M&A Deal Summary |
|
|---|---|
| Date | 2014-12-01 |
| Target | hameln rds |
| Sector | Life Science |
| Buyer(s) | Siegfried Holding |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1873 |
| Sector | Life Science |
| Employees | 3,432 |
| Revenue | 1.3B CHF (2024) |
Siegfried Holding is a developer and manufacturer of active pharmaceutical ingredients for the research-based pharmaceutical industry as well as the corresponding intermediate steps and controlled substances, and provides development and production services for drugs in finished dosage forms including sterile filling. Siegfried Holding was founded in 1873 and is based in Zofingen, Switzerland.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| Country: Germany M&A | 2 of 2 |
| Year: 2014 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-12-01 |
hameln pharmaceuticals gmbh
Hameln, Germany hameln pharmaceuticals gmbh is a pharmaceutical company offers liquid pharmaceutical products. |
Buy | - |
